- Home
- TSBK vs ACRV Comparison
TSBK vs ACRV Comparison
Compare TSBK & ACRV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSBK
- ACRV
- Stock Information
- Founded
- TSBK 1915
- ACRV 2018
- Country
- TSBK United States
- ACRV United States
- Employees
- TSBK N/A
- ACRV N/A
- Industry
- TSBK Banks
- ACRV Medicinal Chemicals and Botanical Products
- Sector
- TSBK Finance
- ACRV Health Care
- Exchange
- TSBK Nasdaq
- ACRV Nasdaq
- Market Cap
- TSBK 256.3M
- ACRV 247.8M
- IPO Year
- TSBK 1998
- ACRV 2022
- Fundamental
- Price
- TSBK $31.97
- ACRV $6.96
- Analyst Decision
- TSBK
- ACRV Strong Buy
- Analyst Count
- TSBK 0
- ACRV 5
- Target Price
- TSBK N/A
- ACRV $22.40
- AVG Volume (30 Days)
- TSBK 11.8K
- ACRV 47.9K
- Earning Date
- TSBK 10-31-2024
- ACRV 11-13-2024
- Dividend Yield
- TSBK 3.13%
- ACRV N/A
- EPS Growth
- TSBK N/A
- ACRV N/A
- EPS
- TSBK 3.01
- ACRV N/A
- Revenue
- TSBK $74,154,000.00
- ACRV N/A
- Revenue This Year
- TSBK N/A
- ACRV N/A
- Revenue Next Year
- TSBK N/A
- ACRV N/A
- P/E Ratio
- TSBK $10.62
- ACRV N/A
- Revenue Growth
- TSBK N/A
- ACRV N/A
- 52 Week Low
- TSBK $23.93
- ACRV $3.19
- 52 Week High
- TSBK $33.98
- ACRV $11.90
- Technical
- Relative Strength Index (RSI)
- TSBK 53.97
- ACRV 34.20
- Support Level
- TSBK $32.50
- ACRV $7.69
- Resistance Level
- TSBK $33.70
- ACRV $8.54
- Average True Range (ATR)
- TSBK 1.08
- ACRV 0.44
- MACD
- TSBK 0.17
- ACRV -0.10
- Stochastic Oscillator
- TSBK 60.59
- ACRV 3.78
About TSBK Timberland Bancorp Inc.
Timberland Bancorp Inc is a bank holding company. The bank offers a variety of services such as checking accounts, online and mobile banking, savings accounts, home loans, consumer loans, construction loans, business rewards, cash management, small business solutions, and business checking accounts among others. Company also offers loans to real estate, including residential and commercial / multi-family construction loans, one- to four-family residential loans, multi-family loans, commercial real estate loans and land loans. The company mainly operates in the United States.
About ACRV Acrivon Therapeutics Inc.
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.